A class action lawsuit has been filed against Park Ha Biological Technology, accusing the company and some executives of securities fraud through a pump-and-dump scheme. The complaint claims Park Ha's stock price was artificially inflated from $4.00 at IPO to $41.49 via fraudulent promotions and impersonation of financial advisors on social media. This manipulation led to a market collapse, harming investors. The case is open for investors to join as Lead Plaintiff until September 28, 2026.
Park Ha Biological Technology lawsuit news is presented with Pluang's health sector data for context. For readers following health stocks, 59 of 91 US health-sector stocks rose and 31 fell today. Notable movers include NVAX at USD 10.17 with +8.77% change and 100% buy order activity, TXG at USD 78.51 with +8.02% change and balanced buy/sell activity, and SANA at USD 3.12 with +6.85% change and 86% sell order activity, as of Sep 17, 2026 21:11 WIB.
Fluence Energy's stock price target was cut sharply from $15.00 to $4.00 by RBC Capital analyst Christopher Dendrinos after the company slashed its 2026 revenue forecast from $3.00 billion to $2.40 billion. The company now expects an adjusted EBITDA ...
Regency Centers reported solid Q2 2026 results with Funds From Operations (FFO) at $1.21 per share and a 3.8% growth in same-property Net Operating Income (NOI). The company raised its full-year guidance, signaling confidence in continued growth. Reg...
Ciena reported a 37% revenue increase to $1.67 billion and a 215% rise in adjusted EPS to $2.11 in its fiscal third quarter, driven by strong demand from AI and cloud infrastructure. The company is well positioned to benefit from the AI networking ma...
Maureen Gellerman, Chief Human Resources Officer at Five Below, sold 1,610 shares of the company, generating $401,000 from the transaction. This insider sale may indicate personal financial planning or portfolio rebalancing but does not necessarily r...
ON Semiconductor is focusing on advanced power-density technologies for AI data centers and electric vehicles, aiming for $2.5 billion revenue from AI alone by 2030. Despite a Neutral rating from UBS, the company introduced its Embedded Power Platfor...
